loadpatents
Patent applications and USPTO patent grants for Howard; Harry Ralph.The latest application filed is for "cycloalkyl-diamines for the treatment of inflammation".
Patent | Date |
---|---|
Cycloalkyl-diamines for the treatment of inflammation Grant 11,426,411 - Godek , et al. August 30, 2 | 2022-08-30 |
Cycloalkyl-diamines for the treatment of pain Grant 11,007,200 - Godek , et al. May 18, 2 | 2021-05-18 |
Cycloalkyl-Diamines for the Treatment of Inflammation App 20210060023 - Godek; Dennis Michael ;   et al. | 2021-03-04 |
Cycloalkyl-Diamines for the Treatment of Pain App 20210052594 - Godek; Dennis Michael ;   et al. | 2021-02-25 |
Bicyclic antiparasitic compounds Grant 10,351,552 - Howard , et al. July 16, 2 | 2019-07-16 |
Bicyclic Antiparasitic Compounds App 20190177304 - Howard; Harry Ralph ;   et al. | 2019-06-13 |
Kappa opioid receptor compounds Grant 9,700,563 - Godek , et al. July 11, 2 | 2017-07-11 |
Compounds for treatment of alzheimer's disease Grant 9,517,232 - Godek , et al. December 13, 2 | 2016-12-13 |
Antiprotozoal compounds Grant 9,475,788 - Godek , et al. October 25, 2 | 2016-10-25 |
Kappa Opioid Receptor Compounds App 20160235759 - Godek; Dennis Michael ;   et al. | 2016-08-18 |
Histamine-3 Receptor Antagonists App 20160237052 - Godek; Dennis Michael ;   et al. | 2016-08-18 |
Cycloalkyl-diamines for neurodegenerative disorders Grant 9,381,170 - Godek , et al. July 5, 2 | 2016-07-05 |
Compounds for Treatment of Alzheimer's Disease App 20160158209 - Godek; Dennis Michael ;   et al. | 2016-06-09 |
Cycloalkyl-Diamines For Neurodegenerative Disorders App 20160151308 - Godek; Dennis Michael ;   et al. | 2016-06-02 |
Antiprotozoal compounds Grant 9,346,777 - Godek , et al. May 24, 2 | 2016-05-24 |
Anti-cancer cycloalkyl diamines Grant 9,345,673 - Godek , et al. May 24, 2 | 2016-05-24 |
Anti-Cancer Cycloalkyl Diamines App 20160101068 - Godek; Dennis Michael ;   et al. | 2016-04-14 |
Kappa opioid receptor compounds Grant 9,284,291 - Godek , et al. March 15, 2 | 2016-03-15 |
Cycloalkyl-diamines for CNS disorders Grant 9,283,196 - Godek , et al. March 15, 2 | 2016-03-15 |
Antiprotozoal Compounds App 20160039799 - Godek; Dennis Michael ;   et al. | 2016-02-11 |
Kappa Opioid Receptor Compounds App 20160031844 - Godek; Dennis Michael ;   et al. | 2016-02-04 |
Antiprotozoal amidine compounds Grant 9,169,237 - Godek , et al. October 27, 2 | 2015-10-27 |
Cycloalkyl-diamines Grant 9,126,891 - Godek , et al. September 8, 2 | 2015-09-08 |
Cycloalkyl-Diamines App 20150210626 - Godek; Dennis Michael ;   et al. | 2015-07-30 |
Antiprotozoal Compounds App 20150038507 - Godek; Dennis Michael ;   et al. | 2015-02-05 |
Aralkyl and aralkylidene heterocyclic lactams and imides Grant 6,921,760 - Howard July 26, 2 | 2005-07-26 |
Aralkyl and aralkylidene heterocyclic lactams and imides Grant 6,627,627 - Howard September 30, 2 | 2003-09-30 |
Aralkyl and aralkylidene heterocyclic lactams and imides App 20020147194 - Howard, Harry Ralph | 2002-10-10 |
Aralkyl And Aralkylidene Heterocyclic Lactams And Imides App 20020091118 - Howard, Harry Ralph | 2002-07-11 |
Aralkyl And Aralkylidene Heterocyclic Lactams And Imides App 20020091117 - Howard, Harry Ralph | 2002-07-11 |
Aralkyl and aralkylidene heterocyclic lactams and imides App 20020091119 - Howard, Harry Ralph | 2002-07-11 |
Aralkyl and aralkylidene heterocyclic lactams and imides App 20020072519 - Howard, Harry Ralph | 2002-06-13 |
Aralkyl and aralkylidene heterocyclic lactams and imides App 20020049214 - Gibbs, Megan Ann ;   et al. | 2002-04-25 |
Optically active 3-[(2-Piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phe- nyl]-2-pyrrolidinone compounds as 5-HT 1D receptor selective antagonists App 20010039280 - Howard, Harry Ralph ;   et al. | 2001-11-08 |
Arylacrylamide derivatives Grant 6,258,953 - Howard , et al. July 10, 2 | 2001-07-10 |
NK-1 receptor antagonists for the treatment of cancer Grant 6,194,436 - Howard February 27, 2 | 2001-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.